BioWorld MedTech

Nov. 20, 2015

SCS Teeming with Competition: St. Jude earns FDA nod for Proclaim, looks to gain ground within SCS market

With an FDA approval of its Proclaim elite spinal cord stimulation (SCS) system in hand, St. Jude Medical Inc. (St. Paul, Minn.) could find itself poised to take a greater share of the SCS market. Read More

Inside the Beltway: Support for LDT discussion draft broad, but FDA wary of deadlines

Targeting the microbiome: Nutritional value of food depends critically on the gut of the eater

Domestic Products have edge: Chinese firms encouraged to pursue international investment opportunities

Old drug performing new tricks: Genentech explores new delivery for longstanding wet AMD drug

IPO floodgates open: Success of JOBS Act leading to higher IPO costs for biotechs

Agreements/contracts: AdvaMed signs strategic cooperation accord with China

Financings: Fractyl extends series C, for round total of $57M

Product briefs

Briefly Noted

MDD's Diagnostics Extra

Today's news in brief

BioWorld

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

Astellas’ ASP-2246 shows promise in stroke management

BioWorld Science

Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...